Intravenous Versus Oral Iron Therapy for Postpartum Anemia | ||||
Benha Journal of Applied Sciences | ||||
Article 2, Volume 5, Issue 2 part (1), February 2020, Page 7-13 PDF (564.98 K) | ||||
Document Type: Original Research Papers | ||||
DOI: 10.21608/bjas.2020.135431 | ||||
View on SCiNiTO | ||||
Authors | ||||
M.R. Fayed; M.A. Mahmoud; A.S. Ebrahem; A.K. Ibrahim | ||||
Professor of Obstetrics and Gynecology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
Abstract | ||||
Postpartum iron deficiency anemia (IDA) is a common problem throughout the world. Various treatment modalities like oral iron therapy, parenteral iron therapy and blood transfusion are used to treat anemia in the postpartum period. This study aimed to compare efficacy, safety, tolerability and side effects of treatment with either intravenous iron sucrose or oral ferrous gluconate for postpartum iron deficiency anemia to ascertain whether administering intravenous iron sucrose to women with postpartum anemia results in higher hemoglobin concentration and improved iron stores than using standard treatment with oral iron. This comparative, randomized and prospective study conducted in Obstetrics and Gynecology Department of Benha University Hospital and Benha Teaching Hospital in the period from 1/11/2018 to 30/9/2019. This study was carried on 60 women with postpartum iron deficiency anemia. The inclusion criteria was hemoglobin concentration | ||||
Keywords | ||||
Ferritin; Oral ferrous gluconate; Intravenous iron sucrose; Postpartum iron deficiency anemia | ||||
Statistics Article View: 139 PDF Download: 415 |
||||